C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2004
11/30/2004	US6825343 1,3-dipolar cycloadditions to polypyrrolic macrocycles
11/30/2004	US6825184 For use as anti-inflammatory agents
11/30/2004	US6824712 Tetrazaporphyrine derivative, plastic resin and solvent; color purity and contrast
11/30/2004	CA2305307C Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents
11/30/2004	CA2282477C Improved methods of making cross-bridged macropolycycles
11/25/2004	WO2004101574A1 Process and apparatus for preparing metal or nonmetal phthalocyanine
11/25/2004	WO2004101569A1 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
11/25/2004	WO2004101568A1 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
11/25/2004	WO2004101567A1 2-SUBSTITUTED PHENYL -6,8-DIALKYL-3H-IMIDAZOLE [1,5a][1,3,5] TRIAZINE -4- ONE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF
11/25/2004	WO2004101564A1 Pyrimidine derivatives possessing cell-cycle inhibitory activity
11/25/2004	WO2004101562A2 Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
11/25/2004	WO2004101558A1 2-imidazo-benzothiazoles as adenosine receptor ligands
11/25/2004	WO2004101554A1 New indole derivatives as factor xa inhibitors
11/25/2004	WO2004101517A1 Carbazole derivative, organic semiconductor device, light-emitting device, and electronic device
11/25/2004	WO2004101516A2 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine
11/25/2004	WO2004100960A2 Anti-inflammatory phosphonate compounds
11/25/2004	WO2004085438A3 Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents
11/25/2004	WO2004054498A3 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
11/25/2004	WO2004050657A3 COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE
11/25/2004	WO2004021984A3 Heterocyclic aromatic compounds useful as growth hormone secretagogues
11/25/2004	WO2004007407A3 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
11/25/2004	US20040236141 reacting oxy nitriles with solutions of inorganic acid in an alcohols, to form carbocyclic oxy esters and isomers, used as chemical intermediates for angiotensin converting enzyme inhibitors
11/25/2004	US20040236117 (ML3000); cyclization of 2,2-dimethyl-3-benzyloyl nitrile by reduction and catalytic hydrogenation; halophenylation with omega-bromo-4-chloroacetophenone; reaction with oxalyl chloride, reduction with hydrazine, and acidification; decreased standing times, improved yields; cyclooxygenase inhibitor
11/25/2004	US20040236106 Method of selectively synthesising triethylenediamine
11/25/2004	US20040236099 Intramolecular amidation of sulfamates catalyzed by metalloporphyrins
11/25/2004	US20040235962 Conformationally restricted polyamine analogs as disease therapies
11/25/2004	US20040235924 antidepressants; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches;drug addition; antiinflammatory agents
11/25/2004	US20040235886 Gyrase inhibitors and uses thereof
11/25/2004	US20040235872 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
11/25/2004	US20040235871 A hexahydro-1,5,6,8-tetraaza-acenaphthylene or -1,3,4-triazaphenalene derivatives; treatment of depression and anxiety; inflammatory bowel disease; treatment of conditions mediated by corticotropin-releasing factor
11/25/2004	US20040235870 Protein kinase inhibitors
11/25/2004	US20040235867 Drugs used for signal transduction modulation, and for prophylaxis of angiogenesis, cancers, tumors, atherosclerosis, vision disorders and inflammatory diseases in mammals
11/25/2004	US20040235865 Imidazo[1,2-a]pyrimidine and fungicidal compositions containing thereof
11/25/2004	US20040235864 Jun kinase inhibitors
11/25/2004	US20040235857 Crystalline therapeutic agent
11/25/2004	US20040235844 Imidazotriazinone derivatives as ligands for GABA receptors
11/25/2004	US20040235838 Use of 2-alkoxyphenol-substituted imidazotriazinones
11/25/2004	US20040235823 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor
11/25/2004	US20040235820 Preparation of hymenialdisine derivatives and use thereof
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235814 Administering compounds such as 1-[1-methylene-4-(bromo-methylene)phenylene]-4,8,11-tris(diethoxyphosphoryl-1,4,8,11-tetraazacyclotetra-decane to modulate a chemokine receptor
11/25/2004	US20040235753 Oxytocin agonists
11/25/2004	US20040234958 Surface enhanced (resonance) Raman scattering with 2,4,6-trinitrostyryl-1H-benzotriazole; for detection of explosives and drugs; drug screening
11/25/2004	US20040234495 Antitumor agents and process for producing the same
11/25/2004	US20040231558 Has a clear hue, high light fastness and high moisture resistance
11/25/2004	DE10320785A1 6-Arylmethyl-substituierte Pyrazolopyrimidine 6-arylmethyl-substituted pyrazolopyrimidines
11/25/2004	DE102004004142A1 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine 6-Cyclylmethyl- and 6-substituted-alkylmethyl pyrazolopyrimidines
11/25/2004	CA2526066A1 New indole derivatives as factor xa inhibitors
11/25/2004	CA2525447A1 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine
11/25/2004	CA2525124A1 Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
11/25/2004	CA2523959A1 2-imidazo-benzothiazoles as adenosine receptor ligands
11/24/2004	EP1480032A1 Reagent for determining the absolute configuration of chiral compound and determination method
11/24/2004	EP1479683A1 Process for the synthesis of hexanitrohexaazaisowurtzitane in 2 steps from a primary amine
11/24/2004	EP1479677A1 New indole derivatives as factor xa inhibitors
11/24/2004	EP1479670A1 Novel fused ring indazole compounds
11/24/2004	EP1478713A1 Fluorescent compositions comprising diketopyrrolopyrroles
11/24/2004	EP1478646A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478357A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
11/24/2004	EP1478339A1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
11/24/2004	EP1411949A4 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors
11/24/2004	EP1185536B1 Hemisynthetic method and intermediates thereof
11/24/2004	EP1107971B1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
11/24/2004	EP0979231B1 Condensed pyridazine derivatives, their production and use
11/24/2004	CN1549817A Pyrrolo pyrimidines, process for their preparation, their use and pharmaceutical compositions containing them
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1549729A 化合物 Compound
11/24/2004	CN1549712A Antitumor agents and process for producing the same
11/24/2004	CN1549711A Use of condensed pyrrole compound in treatment of articular cartilage and bone tissue under cartilage degeneration
11/24/2004	CN1548438A 2-substituted phenyl-6,8-dialkyl-3H-imidazolyl [1,5 alpha] [1,3,5]-trizin-4-one derivative and its prepn and medicine use
11/24/2004	CN1548422A Super-phthalocyanine compound with six isoindole structure subunits in laver oxazine cycle and its synthesis and use
11/24/2004	CN1176902C New esters derived from substituted phenyl-cyclohexyl compounds
11/23/2004	US6822098 Carbocyclic carbo, oxo amines such as n-heptyl-3-methyl-4-oxo -1,4-dihydroquinoline-2-carboxamide, used for prophylaxis of gastrointerstinal disorders
11/23/2004	US6822092 Expanded porphyrins and a method for synthesis thereof
11/23/2004	US6821993 Bioavailable small molecule mimetics of neurotrophic factors that are orally bioavailable and can readily penetrate the blood-brain barrier
11/23/2004	US6821984 Ring fused pyrazole derivatives as CRF antagonists
11/23/2004	US6821971 For prophyalxis of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease (ibs), septic shock, cardiopulmonary dysfunction, acute respiratory disease, cachexia
11/23/2004	US6821964 For prophylaxis and therapy of diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation
11/23/2004	CA2135768C Indolocarbazole imides and the use thereof
11/18/2004	WO2004099339A1 Organic electroluminescent device and platinum compound
11/18/2004	WO2004099213A2 Pyrrolo (1,2-b) pyridazine compounds and their use as crf-1 receptor antagonists
11/18/2004	WO2004099212A1 Heterocyclyl-substituted dihydroquinazolines and use thereof as an antiviral agent
11/18/2004	WO2004099211A1 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines
11/18/2004	WO2004099210A1 6-arylmethyl-substituted pyrazolopyrimidines
11/18/2004	WO2004099209A1 Fused pyrimidine derivatives with crf activity
11/18/2004	WO2004099164A1 Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating hcv infection
11/18/2004	WO2004099152A1 Process for the preparation of carbostyril derivatives, such as aripiprazole and its intermediates
11/18/2004	WO2004099134A2 Glutaminyl based dp iv-inhibitors
11/18/2004	WO2004098608A1 Pyrazolo [4, 3-d]pyrimidines, processes for their preparation and methods of use
11/18/2004	WO2004098591A2 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
11/18/2004	WO2004098590A1 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	WO2004098589A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	WO2004098520A2 Compounds and compositions as protein kinase inhibitors
11/18/2004	WO2004043350A3 PURIFIED COMPOUNDS THAT INHIBIT INTRACELLULAR α4/PAXILLIN BINDING
11/18/2004	WO2003037900A3 Pyrazolopyrimidines
11/18/2004	US20040229923 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
11/18/2004	US20040229902 For therapy and prophylaxis of Alzheimer's disease and other diseases relating to the deposition of amyloid protein
11/18/2004	US20040229893 Substituted benzothiazole amide derivatives
11/18/2004	US20040229890 For lowering blood glucose
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists

1 ... 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 ... 573